Simultaneous binding of bFGF to both FGFR and integrin maintains properties of primed human induced pluripotent stem cells.

Authors:
Cheng YS; Taniguchi Y; Yunoki Y; Masai S; Nogi M and 3 more

Journal:
Regen Ther

Publication Year: 2023

DOI:
10.1016/j.reth.2023.12.008

PMCID:
PMC10788407

PMID:
38226057

Journal Information

Full Title: Regen Ther

Abbreviation: Regen Ther

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Engineering, Biomedical

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of competing interest K. S. is a co-founder and shareholder of Matrixome, Inc. Y.T. holds a position as a Project Leader at Matrixome Inc."

Evidence found in paper:

"This study was supported by Core Center for iPS Cell Research from 10.13039/100009619Japan Agency for Medical Research and Development (JP21bm0104001) and the iPS Cell Research Fund. We thank Dr. M. Zhao for providing advice about antibodies for IB, Drs. M. Iwasaki, C. Akifuji, T. Imai, and C. Y. Lin for scientific discussions, and Dr. K. Hui for reading the manuscript."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025